The three subsets identified as more prevalent in the tumour (CAF-S1, CAF-S4 and CAF-S5) were investigated by staining for CAF markers FAP, αSMA, PDPN, CD90 and FSP1 in a cohort of 163 patients that were part of a TMA. This evidence concerns the gene S100A4 and neoplasm.